Cargando…

The effects of selenium on tumor growth in epithelial ovarian carcinoma

OBJECTIVE: Epidemiological studies suggest that selenium protects against the development of several cancers. Selenium (sodium selenite) has been reported to interfere with cell growth and proliferation, and to induce cell death. In this study, we tested whether selenium could have growth-inhibiting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jin Sun, Ryu, Ji Yoon, Jeon, Hye-Kyung, Cho, Young Jae, Park, Young Ae, Choi, Jung-Joo, Lee, Jeong-Won, Kim, Byoung-Gie, Bae, Duk-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Gynecologic Oncology and Colposcopy 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395015/ https://www.ncbi.nlm.nih.gov/pubmed/22808362 http://dx.doi.org/10.3802/jgo.2012.23.3.190

Ejemplares similares

The anti-cancer effects of itraconazole in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2017)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
por: Park, Jin-Young, et al.
Publicado: (2016)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Ovarian metastasis from pulmonary adenocarcinoma
por: Jung, Young-Eun, et al.
Publicado: (2013)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
por: Lee, Yoo-Young, et al.
Publicado: (2019)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020)

Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancer
por: Kang, Sokbom, et al.
Publicado: (2011)

Primary ovarian choriocarcinoma mimicking ectopic pregnancy
por: Heo, Eun Jin, et al.
Publicado: (2014)

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
por: Kim, Jihye, et al.
Publicado: (2018)

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
por: Paik, E Sun, et al.
Publicado: (2019)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study
por: Jang, Hye-In, et al.
Publicado: (2017)

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
por: Seo, Jun Hyeong, et al.
Publicado: (2019)

Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013)

Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients
por: Noh, Jae Myoung, et al.
Publicado: (2012)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix
por: Jeong, Bae Kwon, et al.
Publicado: (2011)

Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer
por: Jeong, Bae Kwon, et al.
Publicado: (2013)

Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor
por: Kang, Jun-Hyeok, et al.
Publicado: (2020)

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
por: Kim, Hyun-Soo, et al.
Publicado: (2015)

Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
por: Kim, Nalee, et al.
Publicado: (2021)

Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features
por: Kim, Nalee, et al.
Publicado: (2021)

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
por: Paik, E Sun, et al.
Publicado: (2018)

Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer
por: Yang, Kyungmi, et al.
Publicado: (2017)

Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
por: Song, Taejong, et al.
Publicado: (2017)

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
por: Choi, Chel Hun, et al.
Publicado: (2008)

Single-port access laparoscopic staging operation for a borderline ovarian tumor
por: Yoon, Aera, et al.
Publicado: (2011)

Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival
por: Noh, Kyoung Won, et al.
Publicado: (2022)

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea
por: Lee, Hye-joo, et al.
Publicado: (2018)

Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis
por: Kim, Jihye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6nd17r2j5kukug50qok5vilnp8